🧬Tidera Health

Tidera provides educational trial discovery tools and does not provide medical advice or determine eligibility. Always discuss options with your care team.

Clinical Trials for Rare Diseases — Find Recruiting Studies

Search trials for rare genetic disorders, orphan diseases, lysosomal storage diseases, and conditions with limited approved treatments.

🔍 Search Rare Diseases Trials →

About Rare Diseases Clinical Trials

Over 7,000 rare diseases affect an estimated 30 million Americans, yet fewer than 5% have FDA-approved treatments. Clinical trials are often the only pathway to experimental therapy for rare disease patients. Orphan drug designation, natural history studies, and gene therapy trials are all active areas with dedicated patient advocacy organizations that can help navigate access.

Browse by Condition

Quick Search by Condition

Learning Center: Rare Diseases

Frequently Asked Questions: Rare Diseases Clinical Trials

What is an orphan drug clinical trial?
Orphan drug designation applies to drugs targeting diseases affecting fewer than 200,000 Americans. Orphan drug trials benefit from FDA incentives including tax credits, fee waivers, and 7 years of market exclusivity upon approval.
How do I find clinical trials for a condition with very few patients?
For very rare diseases, patient advocacy organizations often maintain disease-specific registries that connect patients with researchers. Natural history studies — which collect longitudinal data without testing a treatment — are common entry points.
What if there are no clinical trials for my rare condition?
If no trials are recruiting, ask about: (1) expanded access / compassionate use programs, (2) natural history or registry studies, (3) patient advocacy groups that facilitate research connections, or (4) pharmaceutical company patient assistance programs for investigational drugs.

Data source: All trial data sourced from ClinicalTrials.gov, the official U.S. registry maintained by the National Library of Medicine. Tidera Health is independent and not affiliated with ClinicalTrials.gov or the NLM.